May 1 (Reuters) - Monogram Orthopaedics Inc MGRM.O :
* MONOGRAM ORTHOPAEDICS INC - PROVIDES REGULATORY UPDATE
FOLLOWING
MEETING WITH FDA
* MONOGRAM ORTHOPAEDICS INC - 510(K) SUBMISSION WITH FDA
ACCELERATED FOR EARLY SECOND HALF OF 2024
* MONOGRAM ORTHOPAEDICS - PROVIDED UPDATE RELATED TO
REGULATORY,
COMMERCIALIZATION PATH FOR ITS MBÔS SURGICAL SYSTEM FOLLOWING
ITS MEETING WITH FDA
* MONOGRAM ORTHOPAEDICS INC - ON APRIL 19, MONOGRAM
RECEIVED
WRITTEN FEEDBACK FROM FDA REGARDING THE COMPANY'S Q1 2023
PRE-SUBMISSION REQUEST
* MONOGRAM ORTHOPAEDICS - BELIEVES FEEDBACK WAS
COMPREHENSIVE AND
WILL BE ADVANTAGEOUS FOR PREPARING SUCCESSFUL 510(K) SUBMISSION
TO OBTAIN CLEARANCE
Source text for Eikon: ID:n0001104659-24-055243
Further company coverage: MGRM.O
(Reuters.Briefs@thomsonreuters.com)